YY2 and neoplasm: Overall, our results clearly show that YY2 could suppress the tumor‐initiating capacity of HCC cells by inhibiting DRP1‐mediated CSC mitochondrial fission, thereby downregulating CSC asymmetric division and subsequently, exhausting the CSC pool (Figure 8H).